NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW)

CUSIP: N62509117

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / *W EXP 99/99/999
Total 13F shares
17,000
Share change
+17,000
Total reported value
$35,530
Price per share
$2.09
Number of holders
1
Value change
+$35,530
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP N62509117?
CUSIP N62509117 identifies NAMSW - NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW) as of Q2 2022

As of 30 Jun 2022, NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 17,000 shares. The largest 1 holders included PEAK6 Investments LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.